Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort - Test2 - elhamkhani - TriplyDB

Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort

Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort

http://www.wikidata.org/entity/Q33996059

about

Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014 The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception Neuroimaging biomarkers of neurodegenerative diseases and dementia Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers Individualized Gaussian process-based prediction and detection of local and global gray matter abnormalities in elderly subjects The clinical value of large neuroimaging data sets in Alzheimer's disease Imaging genetics in attention-deficit/hyperactivity disorder and related neurodevelopmental domains: state of the art.Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations.Mapping the effect of the apolipoprotein E genotype on 4-year atrophy rates in an Alzheimer disease-related brain network Advances in longitudinal studies of amnestic mild cognitive impairment and Alzheimer's disease based on multi-modal MRI techniques.Does the brain shrink as the waist expands?Midlife managerial experience is linked to late life hippocampal morphology and function.Advances in MRI biomarkers for the diagnosis of Alzheimer's disease.The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2 APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.Improving Dual-Task Walking Paradigms to Detect Prodromal Parkinson's and Alzheimer's Diseases.Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease.Dissociation of Down syndrome and Alzheimer's disease effects with imaging.The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease.Emerging imaging tools for use with traumatic brain injury research.The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis.Mediterranean Diet and Magnetic Resonance Imaging-Assessed Brain Atrophy in Cognitively Normal Individuals at Risk for Alzheimer's Disease.APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years Multiscale adaptive marginal analysis of longitudinal neuroimaging data with time-varying covariates.Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease.Two Alzheimer's disease risk genes increase entorhinal cortex volume in young adults Association of cancer history with Alzheimer's disease onset and structural brain changes.A review of neuroimaging biomarkers of Alzheimer's disease.Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease.BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease.Evaluating Alzheimer's disease progression using rate of regional hippocampal atrophy.Structural brain changes in normal individuals with a maternal history of Alzheimer's.Entorhinal cortex volume is associated with episodic memory related brain activation in normal aging and amnesic mild cognitive impairment.Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.Protective variant for hippocampal atrophy identified by whole exome sequencing.Predictive Models Based on Support Vector Machines: Whole-Brain versus Regional Analysis of Structural MRI in the Alzheimer's Disease Selective changes in white matter integrity in MCI and older adults with cognitive complaints.

P2860

Q26801629-7A3A8F6E-A43D-4845-BFBE-8B7D3883849C Q27006831-18CE22B2-E78C-4F32-BDC9-1215D8F55033 Q27691820-9CFF7872-9D93-4BC5-A59C-5E9D0948B99A Q28542010-0CA361E0-1580-42E0-8A8F-6343CEB78BC0 Q28656446-0CB80ED8-408E-442E-BF20-EF055B6EDBA3 Q28709465-495557D9-2268-4347-AA01-EB0C98E506F0 Q30240118-F3F8341D-3C2C-4FAF-9E14-DF1AC1AF9D18 Q30664513-ED04B2B0-40DA-4CAA-9517-BB143C15F0C3 Q30744917-0E2499FC-0D13-4F55-A214-9E8AAF8CC68F Q30765803-22CB83B5-9600-4254-8C2C-86A3B4096152 Q30809609-BD6AEC0F-F870-4B74-AAA9-4C10B2B0A71A Q30847161-BEAAE76F-6EE0-4980-81ED-24FAF45D47BC Q30870223-983BA506-729D-4290-98B2-A198D17351E5 Q30874688-EA1D20BF-42DF-4D36-ACFA-AC0BAB6353C7 Q30971403-5D708E7F-702D-4DA3-A11E-3D301FF34428 Q30981669-BD244923-E9B1-40F3-BD20-954437E1572A Q33690208-B37B1AE0-2AEE-45FD-86B9-F026EEA28545 Q33710775-C2F6DB0D-3E27-4650-9D93-33804803C8DF Q33759008-D4DBF218-DAA5-4468-BBFC-EC09F4925546 Q33816076-0F4CB2B2-9440-42DF-BFD9-5FF1A0A5304C Q33841363-9FC6A971-1E8E-4775-98E0-8FF0B3AA1D40 Q33970379-167F4518-978A-4894-8384-5384030CD805 Q34065449-2775F8EB-C77F-4022-84B3-AF239C9668BF Q34176310-2AADC9B2-BFD8-419B-AADB-AB5811DFF102 Q34193658-78890524-FA2B-4102-8DBC-B83DA5B44D54 Q34226538-35FFCDDA-FD79-4547-8651-A75919F94F69 Q34253546-430DDEDC-CDAE-4D11-B096-FB19E515EAC5 Q34277495-D2588E62-81C7-4012-9E08-2E68AF807A94 Q34292129-51D5397D-EF10-44F1-9771-DF0D87DBE028 Q34433766-F8006E89-47BE-4792-8B4A-414C6573E8CC Q34571189-0FACE1ED-E6BF-4612-96EC-71F0904BCB39 Q34647037-4E7A92F4-5B86-44CB-A8AC-700AEC73D52F Q34797000-F2288E53-C142-42B9-86F8-9DDA3AAFB5E7 Q34949358-D45D4D19-7018-4D3B-ADE8-5ECD18137C96 Q35046339-60EAD53A-57DF-4BD9-98D4-11A54E42367B Q35190344-F2D6C76D-356B-4C0A-A945-E2C5A4BEB299 Q35229601-D56A179F-5002-4797-8380-98051FA41ED4 Q35291942-2D898650-DA7B-461F-8C51-9E728195E47E Q35305144-CEA746A6-9EE6-4FC4-9735-7AFC842983C3 Q35606682-15A62253-5918-4DD5-80B2-8E0EB811B0F4

P2860

Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort

http://www.wikidata.org/entity/Q33996059

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort

@ast

Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort

@en

type

label

Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort

@ast

Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort

@en

prefLabel

Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort

@ast

Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort

@en

P1433

Q33996059-B22277B2-EB62-42BD-A645-DC4AD0A78FF9

P1476

Q33996059-16EE1E65-524D-4C98-A146-0A636CF35C08

P2093

Q33996059-2C82ABCC-1BAB-4FA1-9E2A-133CB80FEA0C

Q33996059-42B19E65-2A9C-4B62-B55F-72F59E73CA44

P2860

Q33996059-02AE6283-16C3-40D7-998C-EFAE55A59D22

Q33996059-06293B98-8816-43B9-8FAE-0EC4A2506458

Q33996059-09356698-DDD8-4B60-AE98-26E81464BA1B

Q33996059-0DC82070-F615-4B20-9A5E-F6113FBF6699

Q33996059-10D5A605-ACAD-474D-B8C3-1D9E7414A9C8

Q33996059-1473B431-ABA1-4D20-8BAB-27FD0BF66865

Q33996059-1588B59E-1681-4F29-97E6-C2437C358482

Q33996059-16B76E43-2EB8-4F98-9ACB-71F9168CA9CA

Q33996059-189C5B1E-F1CC-4F7E-9D39-6BD2FAE605F1

Q33996059-19385FFA-107B-42B5-8348-875526D90526

P304

Q33996059-61EEEDFF-9BAE-4C7A-90F7-6494BF2DFD00

P31

Q33996059-09B6B4D2-AC61-442E-9B04-8D08543B18A1

P356

Q33996059-DFD7B741-628E-4A58-A544-5C40242524F3

P433

Q33996059-37564364-EF40-4C8B-8B4B-E841801FA09C

P478

Q33996059-4FF7207A-985E-4AFE-B57D-001CAFD3419D

P50

Q33996059-08B22E6C-CC03-465B-86E5-2B819BA78C13

Q33996059-17804510-3CC7-45D7-95FE-B1366B72834B

Q33996059-1EFDE64F-69D9-4B46-B021-FE8638724E7C

Q33996059-37E47EA3-F62E-4BE9-A502-9EFE0E470CE1

Q33996059-49253231-2C86-400D-871D-B127D9B83E29

Q33996059-8E4E6866-520B-47E2-97F3-BF692971D6BB

Q33996059-9E2C7C84-3BBE-4CF0-8F80-26B02A3FE30F

Q33996059-BB32FD22-A89D-43DA-A7B9-2CB9CC755CC9

Q33996059-CF62E4E2-F0A8-48BA-B034-107FF35994FB

P577

Q33996059-A685F1AA-00B5-41CB-9142-89DC99583A67

P5875

Q33996059-211D7769-2A05-43E4-9ED1-79D310974483

P698

Q33996059-10C82BAB-B62A-432F-A95F-24757FA69B1D

P921

Q33996059-70037AFB-2527-4961-90A7-4A7DDC7A3FB9

P932

Q33996059-DBE4582E-3017-475B-84E6-EC1A89E7FC3B

P356

J.NEUROBIOLAGING.2010.04.029

P1433

Neurobiology of Aging

P1476

Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort

@en

P2093

Danielle J Harvey

http://www.w3.org/2001/XMLSchema#string

John D West

http://www.w3.org/2001/XMLSchema#string

P2860

Role of Genes and Environments for Explaining Alzheimer Disease

Global prevalence of dementia: a Delphi consensus study

The clinical use of structural MRI in Alzheimer disease

Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline

MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

Cortical Surface-Based Analysis

Voxel-based morphometry--the methods

Mild cognitive impairment: clinical characterization and outcome

P304

1401-1418

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROBIOLAGING.2010.04.029

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Andrew J. Saykin

Alzheimer's Disease Neuroimaging Initiative

Michael W. Weiner

Brenna C. McDonald

Shannon L. Risacher

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45149756

http://www.w3.org/2001/XMLSchema#string

P698

20620664

http://www.w3.org/2001/XMLSchema#string

P921

P932

2904350

http://www.w3.org/2001/XMLSchema#string